CClinicalTrials.gg
CompletedNCT06520358Updated Jan 9, 2026

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

An interventional study of Acute Intermittent Hypoxia (AIH) and Task specific Airway Protection Training in Traumatic Brain Injury, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by University of Florida · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Study summary

Acute intermittent hypoxia (AIH) involves 1-2min of breathing low oxygen air to stimulate neuroplasticity. Animal and human studies show that AIH improves motor function after neural injury, particularly when paired with task-specific training. Using a double blind cross-over study we will test whether AIH and task-specific airway protection training improves airway protection more than training alone in individuals with chronic mild-moderate traumatic brain injury (TBI).

Read the detailed description

Recent studies have found that acute intermittent hypoxia (AIH)-or repetitive exposure to brief episodes of low inspired oxygen--is a promising new strategy that can help restore motor function by promoting neuroplasticity throughout the central nervous system (CNS). Both rodent and human studies show that motor function is further enhanced when AIH is paired with task-specific training/rehabilitation (TST). Therefore, this study will investigate the therapeutic potential of combining AIH with a task-specific airway protection training. We propose that the combined use of AIH + TST will enhance the magnitude and duration of TST training alone in individuals with chronic traumatic brain injury.

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • acute intermittent hypoxia
  • rehabilitation
  • airway protection
  • dysphagia
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's enrollment of 5 is below the median of 56 across 1,133 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 21-80 years
  • A mild to moderate traumatic brain injury (TBI) confirmed by medical records
  • A Glasgow Coma Scale score between 9-15
  • Able to consent independently
  • Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study

Exclusion criteria

Exclusion Criteria:

  • Other neurological diagnoses or a diagnosis of a severe psychiatric disorder
  • Severe aphasia preventing a participant from understanding the protocol and consent form
  • Pre-existing hypoxic pulmonary disease
  • History of obstructive lung diseases such as chronic obstructive pulmonary disease (COPD) or significant asthma)
  • Severe hypertension (>160/100)
  • History of head and neck cancer
  • Allergy to barium sulfate
  • Ischemic cardiac disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
5 participants (actual)

Study arms

  • Active comparator
    AIH + TST

    Participants will complete a 5-day intervention blocks where they receive daily AIH followed by task specific airway protection training 60 minutes after the AIH exposure. Each exposure involves a 1-minute delivery of low oxygen (9-11% inspired O2), followed by a 1.5-min interval of room air breathing (21% O2). This method of waiting 45-60 minutes after the delivery of AIH and prior to engaging in task-specific training/rehabilitation enables sufficient time to increase brain derived neurotrophic factor (BDNF) following AIH, thereby augmenting the impact of task-specific training.

    Other: Acute Intermittent Hypoxia (AIH) · Behavioral: Task specific Airway Protection Training

  • Sham comparator
    Sham AIH + TST

    Participants will complete a 5-day intervention blocks where they receive sham AIH followed by task specific airway protection training 60 minutes after the AIH sham exposure. Sham AIH will be delivered using methods identical to AIH, except a normoxic gas mixture (\~21% O2) will be delivered. The gas mixture with normoxic air will effectively serve as a sham.

    Behavioral: Task specific Airway Protection Training · Other: Sham AIH

Interventions

  • OtherAcute Intermittent Hypoxia (AIH)

    Acute intermittent hypoxia refers to brief (acute), repetitive (intermittent) episodes of breathing oxygen-deprived air (hypoxia) alternating with breathing ambient room air.

  • BehavioralTask specific Airway Protection Training

    The vLVC maneuver involves training participants to volitionally prolong closure of the laryngeal vestibule during swallowing, beginning with swallow onset and sustaining closure for at least 2 seconds.

    Also known as: volitional laryngeal vestibule closure (vLVC) training

  • OtherSham AIH

    Sham AIH will be delivered using methods identical to AIH, except a normoxic gas mixture (\~21% O2) will be delivered. The gas mixture with normoxic air will effectively serve as a sham.

06

What researchers measure

Primary outcomes

  1. Duration of laryngeal vestibule closure (dLVC)

    Time in (msec) the laryngeal vestibule stays closed during a swallow

    Time frame: Pre-intervention, 1 day after intervention block and 1-week post intervention

  2. Time to laryngeal vestibule closure (Time-to-LVC)

    Time in (msec) it takes to close the laryngeal vestibule after swallow initiation

    Time frame: Pre-intervention, 1 day after intervention block and 1-week post intervention

Secondary outcomes

  1. Penetration-Aspiration Scale Scores

    The penetration-aspiration scale (PAS) will be used to assess penetration or aspiration; the PAS is an 8-point scale that ranges from 1 (no penetration/aspiration) to 8 (aspiration with no cough response).

    Time frame: Pre-intervention, 1 day after intervention block and 1-week post intervention

07

Study locations

1 site
  • University of Florida
    Jacksonville, Florida 32209, United States
08

References and documents

Publications

  • Vose AK, Welch JF, Nair J, Dale EA, Fox EJ, Muir GD, Trumbower RD, Mitchell GS. Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular disease. Exp Neurol. 2022 Jan;347:113891. doi: 10.1016/j.expneurol.2021.113891. Epub 2021 Oct 9. PubMed 34637802 ↗
  • Welch JF, Sutor TW, Vose AK, Perim RR, Fox EJ, Mitchell GS. Synergy between Acute Intermittent Hypoxia and Task-Specific Training. Exerc Sport Sci Rev. 2020 Jul;48(3):125-132. doi: 10.1249/JES.0000000000000222. PubMed 32412926 ↗
  • Vose A, Humbert I. "Hidden in Plain Sight": A Descriptive Review of Laryngeal Vestibule Closure. Dysphagia. 2019 Jun;34(3):281-289. doi: 10.1007/s00455-018-9928-1. Epub 2018 Jul 30. PubMed 30062547 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06520358
Lead sponsor
University of Florida
Responsible party
Sponsor
First posted
Jul 25, 2024
Start date
Aug 30, 2024
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Jan 9, 2026

Study contacts

Alicia Z Vose, Ph.D.
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion